Genomics Market Research Reports & Industry Analysis
Genomics is dedicated to the study, analysis, and application of genetic materials. As the field of genomics advances, its effects are felt across various industries including healthcare, biotechnology, and personalized medicine. MarketResearch.com offers comprehensive genomics industry reports to help you stay informed in this fast-growing industry.
Genomics Market Size and Analysis
- Our reports cover various genomics markets extensively, including genomics, proteomics, and cell biology technology.
- We provide in-depth insights into market dynamics, offering market size data, growth projections, and analysis of key technological innovations, industry trends, and competitor strategies.
- Additionally, our genomics research highlights emerging trends that could significantly impact the industry. Being aware of these trends is vital for long-term success in an ever-changing landscape.
Insights for Informed Decisions
Our genomics market research reports provide reliable data for making informed decisions, helping you increase revenue and capitalize on emerging opportunities. Our team of research specialists is on standby to assist you by providing tailored recommendations to fit your specific needs. As the genomics field evolves, count on MarketResearch.com for valuable insights to maintain your competitive edge.
Genomics Industry Research & Market Reports
-
Global Difficult-to-Express Proteins Market - 2023-2030
... to exhibit a CAGR of 11.0% during the forecast period (2024-2031). Prokaryotic expression system research and development have increased due to the rising demand for recombinant proteins and this trend is anticipated to fuel market ... Read More
-
Single Cell Analysis Market Size, Share & Trends By Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2029
... growth of this market can be attributed to the increasing focus on personalized medicine. The rising R&D investments pharmaceutical & biotechnology industries is propelling the growth of single-cell analysis. Additionally, factors such as growth in ... Read More
-
Biopreservation Market Report by Product Type (Biopreservation Equipment, Biopreservation Media), Application (Therapeutic Applications, Biobank Applications, Drug Discovery Applications), and Region 2025-2033
... growing focus on personalized medicine among the masses, the increasing investments in research and development (R&D) activities and the rising awareness and understanding of rare diseases are some of the major factors propelling the market. ... Read More
-
Global Urea Cycle Disorder Treatment Market 2025-2029
... the urea cycle disorder treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Peptide Synthesis Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)
... investments and substantial funding for genomics and proteomics research are driving the demand for peptides in drug discovery and therapeutic development. Owing to the rising demand for effective protein-based drugs for the proper treatment process, ... Read More
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Forensic Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the ... Read More
-
Competent Cells
... CAGR of 7.8% over the analysis period 2024-2030. Electrocompetent Cells, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.2 Billion by the end of the analysis ... Read More
-
Human Microbiome
... CAGR of 28.4% over the analysis period 2024-2030. Gastrointestinal Diseases, one of the segments analyzed in the report, is expected to record a 28.6% CAGR and reach US$1.3 Billion by the end of the analysis ... Read More
-
Electron Microscopy and Sample Preparation
... Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2024-2030. Industrial End-Use, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$3.2 Billion ... Read More
-
Ancestry and Relationship Testing
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Online Distribution Channel, one of the segments analyzed in the report, is expected to record a 11.2% CAGR and reach US$1.1 Billion by ... Read More
-
Microbiome Sequencing Services
... at a CAGR of 18.2% over the analysis period 2024-2030. Synthesis Technique, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.3 Billion by the end of ... Read More
-
Gene Delivery Systems
... at a CAGR of 6.5% over the analysis period 2024-2030. Viral Gene Delivery, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$4.1 Billion by the end ... Read More
-
Genomics and Proteomics Reagents, Research Kits and Analytical Instruments
... the year 2024, is expected to reach US$156.5 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2024-2030. Biochips & Microarrays, one of the segments analyzed in the report, is expected ... Read More
-
Alpha Mannosidosis
... CAGR of 11.4% over the analysis period 2024-2030. Bone Marrow Transplant (BMT), one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$6.3 Billion by the end of ... Read More
-
Small Molecule Kinase Inhibitors
... 2030, growing at a CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$27.8 Billion While China is Forecast to Grow at 14.6% CAGR The Small Molecule Kinase Inhibitors market ... Read More
-
Synthetic DNA
... CAGR of 18.7% over the analysis period 2024-2030. Pharmaceuticals & Diagnostics Application, one of the segments analyzed in the report, is expected to record a 20.1% CAGR and reach US$4.5 Billion by the end of ... Read More
-
Synthetic Cells
... CAGR of 21.5% over the analysis period 2024-2030. Pharmaceuticals & Diagnostics Application, one of the segments analyzed in the report, is expected to record a 23.6% CAGR and reach US$3.1 Billion by the end of ... Read More
-
Genomics in Cancer Care
... 2030, growing at a CAGR of 16.7% over the analysis period 2024-2030. Genomics Instruments, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$25.0 Billion by the ... Read More
-
Predictive Genetic Testing and Consumer Genomics
... reach US$20.7 Billion by 2030, growing at a CAGR of 14.4% over the analysis period 2024-2030. Predictive Testing, one of the segments analyzed in the report, is expected to record a 14.3% CAGR and reach ... Read More
-
Recombinant DNA Technology
... at a CAGR of 4.5% over the analysis period 2024-2030. Medical Recombinant DNA Technology, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$77.9 Billion by the ... Read More
-
Molecular Breeding
... CAGR of 17.6% over the analysis period 2024-2030. Marker-Assisted Selection (MAS) Process, one of the segments analyzed in the report, is expected to record a 18.1% CAGR and reach US$11.7 Billion by the end of ... Read More
-
Nutrigenomics
... 16.2% over the analysis period 2024-2030. Nutrigenomics Reagents & Kits, one of the segments analyzed in the report, is expected to record a 17.0% CAGR and reach US$2.0 Billion by the end of the analysis ... Read More
-
Plant Genomics
... CAGR of 8.0% over the analysis period 2024-2030. Molecular Engineering, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$10.5 Billion by the end of the analysis ... Read More
-
Biobanks
... 7.7% over the analysis period 2024-2030. Physical / Real Biobanks, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$108.4 Billion by the end of the analysis ... Read More
-
Animal Genetics
... CAGR of 5.8% over the analysis period 2024-2030. Live Animals, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$7.3 Billion by the end of the analysis ... Read More
Research Assistance
